A survey of aortic disease biorepository participants' preferences for return of research genetic results.
A survey of aortic disease biorepository participants' preferences for return of research genetic results.
复制标题
DOI:
10.1002/jgc4.1341
复制
发表时间:
2021-06
影响因子:
1.9
通讯作者:
Roberts JS
中科院分区:
文献类型:
--
作者:
Love-Nichols J;Uhlmann WR;Arscott P;Willer C;Hornsby W;Roberts JS
There is ongoing debate on whether and what research genetic results to return to study participants. To date, no study in this area has focused on aortopathy populations despite known genes that are clinically actionable. Participants (n=225, 79% male, mean age=61 years) with an aortopathy were surveyed to assess preferences for receiving research genetic results. Participants were ‘very’ or ‘extremely likely’ to want results for pathogenic variants in aortopathy genes with implications for family members (81%) or that would change medical management (76%). Similarly, participants were ‘very’ or ‘extremely likely’ to want actionable secondary findings related to cancer (75%) or other cardiac diseases (70%). Significantly lower interest was observed for non-actionable findings – pathogenic variants in aortopathy genes that would not change medical management (51%) and variants of uncertain significance (38%) (p<0.0001). Higher health and genomic literacy were positively associated with interest in actionable findings. Most participants (>63%) were accepting of any means of return; however, a substantial minority (18-38%) deemed certain technological means unacceptable (e.g., patient portal). Over 90% of participants reported that a range of health professionals, including cardiovascular specialists, genetics specialists, and primary care providers, were acceptable to return results. Participants with aortopathies are highly interested in research genetic results perceived to be medically actionable for themselves or family members. Participants are accepting of a variety of means for returning results. Findings suggest that research participants should be asked what results are preferred at time of informed consent and that genetic counseling may clarify implications of results that are not personally medically actionable.
登录
查看更多内容
影响因子:
37.8
作者:
Go AS;Mozaffarian D;Roger VL;Benjamin EJ;Berry JD;Blaha MJ;Dai S;Ford ES;Fox CS;Franco S;Fullerton HJ;Gillespie C;Hailpern SM;Heit JA;Howard VJ;Huffman MD;Judd SE;Kissela BM;Kittner SJ;Lackland DT;Lichtman JH;Lisabeth LD;Mackey RH;Magid DJ;Marcus GM;Marelli A;Matchar DB;McGuire DK;Mohler ER 3rd;Moy CS;Mussolino ME;Neumar RW;Nichol G;Pandey DK;Paynter NP;Reeves MJ;Sorlie PD;Stein J;Towfighi A;Turan TN;Virani SS;Wong ND;Woo D;Turner MB;American Heart Association Statistics Committee and Stroke Statistics Subcommittee
通讯作者:
American Heart Association Statistics Committee and Stroke Statistics Subcommittee
影响因子:
8.8
作者:
Butrick, Morgan;Kelly, Scott;Schwartz, Marc D.
通讯作者:
Schwartz, Marc D.
影响因子:
8.8
作者:
Christensen, Kurt D.;Uhlmann, Wendy R.;Green, Robert C.
通讯作者:
Green, Robert C.
DOI:
10.12945/j.aorta.2017.17.003
发表时间:
2017-02-01
期刊:
Aorta (Stamford, Conn.)
影响因子:
--
作者:
Brownstein, Adam J;Ziganshin, Bulat A;Elefteriades, John A
通讯作者:
Elefteriades, John A
影响因子:
7.4
作者:
Ahmad, Ferhaan;McNally, Elizabeth M.;Wilcox, Janel E.
通讯作者:
Wilcox, Janel E.